Related Experiment Video
Updated: Sep 18, 2025
08:14
MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
Published on: October 26, 2017
15.8K
The Lithuanian Lung Cancer Screening Model: Results of a Pilot Study
Edvardas Danila1,2, Leonid Krynke3, Audronė Ciesiūnienė4
1Clinic of Chest Diseases, Immunology and Allergology, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Santariškių St. 2, 08661 Vilnius, Lithuania.
Cancers
|June 26, 2025
Summary
Lithuania
Area of Science:
- Public Health
- Radiology
- Oncology
Background:
- Lithuania launched a national lung cancer screening program in 2024.
- The program targets individuals aged 50-70 every three years.
- It aims to detect lung cancer and significant incidental findings.
Purpose of the Study:
- To evaluate the feasibility and organizational efficiency of the new lung cancer screening program.
- To assess the pilot program's potential clinical effectiveness.
Main Methods:
- Three family medicine centers participated in the pilot.
- 1014 individuals aged 50-70 were invited and underwent low-dose chest computed tomography (LDCT).
- Screening followed Lung-RADS v2022 guidelines.
Main Results:
- 76.1% participation rate.
- 1.4% had Lung-RADS category 4 nodules; one case of squamous cell carcinoma detected.
- 25.9% had significant incidental findings (pulmonary, cardiovascular, other).
- 17.6% of participants were referred to specialists.
Conclusions:
- The Lithuanian lung cancer screening model is feasible and well-organized.
- The pilot demonstrates clinical value and readiness for national implementation.
- The program effectively identifies lung cancer and other significant health conditions.
